Sort   by:  
 Page size 
UnknownIdentification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.
Not available
S-EPMC5342567 | biostudies-literature
UnknownHDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL.
Not available
S-EPMC4504978 | biostudies-literature
UnknownThe pseudo-caspase FLIP(L) regulates cell fate following p53 activation.
Not available
S-EPMC7395556 | biostudies-literature
UnknownThe E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
Not available
S-EPMC7329634 | biostudies-literature
UnknownA revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis.
Not available
S-EPMC7054686 | biostudies-literature
UnknownClinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
Not available
S-EPMC7611622 | biostudies-literature
UnknownDexamethasone as an adjuvant to peripheral nerve block.
Not available
S-EPMC6486015 | biostudies-literature
UnknownPerformance characteristics of highly automated HSV-1 and HSV-2 IgG testing.
Not available
S-EPMC11237592 | biostudies-literature
UnknownFunctional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists.
Not available
S-EPMC7612587 | biostudies-literature
GenomicsChIP NS5 Ascl1-ERT2
Here we performed a ChIP-seq experiment on a sample of adherent cultures of mouse neural stem cells (NS5 cell line) under normal growth conditions and upon short term activation (30 minutes) of an inducible version of the proneural factor Mash1/Ascl1 (Ascl1-ERT2). This resulted in the generation of ...
ORGANISM(S): Mus musculus 
2015-02-16 | E-MTAB-2384 | biostudies-arrayexpress
Sort   by:  
 Page size